MaxCyte
MXCT
130 hedge funds and large institutions have $45.9M invested in MaxCyte in 2026 Q1 according to their latest regulatory filings, with 38 funds opening new positions, 30 increasing their positions, 36 reducing their positions, and 19 closing their positions.
100% more first-time investments, than exits
New positions opened: 38 | Existing positions closed: 19
16% more funds holding
Funds holding: 112 → 130 (+18)
1.74% more ownership
Funds ownership: 59.26% → 61% (+1.7%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
17% less repeat investments, than reductions
Existing positions increased: 30 | Existing positions reduced: 36
53% less capital invested
Capital invested by funds: $98M → $45.9M (-$52.1M)
100% less call options, than puts
Call options by funds: $0 | Put options by funds: $1K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CFM
Capricorn Fund Managers
London,
United Kingdom
|
+$7.66M |
| 2 |
BFM
Brooklands Fund Management
London,
United Kingdom
|
+$2.04M |
| 3 |
PLC
Peapod Lane Capital
Bedford Hills,
New York
|
+$1.24M |
| 4 |
Renaissance Technologies
New York
|
+$1.13M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
MFS
Mirabella Financial Services
London,
United Kingdom
|
-$12.7M |
| 2 |
CCM
Cadian Capital Management
New York
|
-$1.83M |
| 3 |
Millennium Management
New York
|
-$1.17M |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$1.08M |
| 5 |
Morgan Stanley
New York
|
-$696K |
MXCT Hedge Fund Activity: Q1 2026 in Review
130 of the 8,126 institutional investors tracked by Wall St. Rank reported a position in MaxCyte (MXCT) for Q1 2026, worth a combined $45.9M — down 53% from $98M a quarter earlier.
Buyers outnumbered sellers: 38 funds opened new MXCT positions and 19 closed out — a net gain of 19 holders — while 30 added to existing stakes and 36 trimmed.
The largest buyer was Capricorn Fund Managers, opening a new position worth an estimated $7.66M. The largest seller was Mirabella Financial Services, exiting entirely with an estimated $12.7M sold.
- 130 institutional investors held MaxCyte (MXCT) as of Q1 2026, up from 112 in Q4 2025.
- Funds reported $45.9M of MaxCyte stock for Q1 2026, down 53% quarter-over-quarter.
- 38 funds opened new MaxCyte positions in Q1 2026 and 19 closed out, a net change of +19 holders.
- The largest MaxCyte buyer in Q1 2026 was Capricorn Fund Managers, an estimated $7.66M added.
- The largest MaxCyte seller in Q1 2026 was Mirabella Financial Services, an estimated $12.7M sold.
Based on aggregated 13F filings for Q1 2026.